Total submissions: 22
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000041095 | SCV000051641 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000041095 | SCV000064786 | benign | not specified | 2015-05-20 | criteria provided, single submitter | clinical testing | p.Ile3956Phe in exon 45B of TTN: This variant is not expected to have clinical s ignificance because it has been identified in 2.2% (145/6608) of Finnish chromos omes, including 1 homozygote, by the Exome Aggregation Consortium (ExAC, http:// exac.broadinstitute.org; dbSNP rs34618570). |
Gene |
RCV000041095 | SCV000238177 | benign | not specified | 2018-03-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000229415 | SCV000286436 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000041095 | SCV000307154 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000041095 | SCV000336075 | benign | not specified | 2015-10-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000619226 | SCV000735103 | benign | Cardiovascular phenotype | 2016-02-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000770112 | SCV000901538 | benign | Cardiomyopathy | 2016-12-28 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000770112 | SCV000995665 | benign | Cardiomyopathy | 2019-01-24 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001528764 | SCV001472795 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839805 | SCV002100836 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839806 | SCV002100837 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839807 | SCV002100838 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839804 | SCV002100839 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001528764 | SCV002563639 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BS2 |
Diagnostic Laboratory, |
RCV001528764 | SCV001741079 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001528764 | SCV001797932 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000041095 | SCV001921824 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001528764 | SCV001929425 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000041095 | SCV001958421 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001528764 | SCV001973194 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Institute of Human Genetics, |
RCV004595901 | SCV005088666 | likely benign | Hypertrophic cardiomyopathy 2 | no assertion criteria provided | clinical testing |